Did you know? CSL is investigating a potential treatment to improve the health of people living with end-stage kidney disease (ESKD). 

Meet Reagan Bender, who has thrived at CSL for 11 years! Starting in sales, Reagan's career has evolved through various roles, showcasing CSL's supportive and collaborative environment. By leveraging mentorship and thinking ahead, Reagan has grown within the organization and made a meaningful impact on patient lives. Discover how CSL can be the perfect place for your professional growth. https://bit.ly/4dDdts8 #CSLCareers #CareerGrowth #Mentorship #GreatPlaceToWork #JoinCSL #PromisingFutures

Some symptoms you can see. Others stay hidden—and hit harder. Life doesn’t stop when you're diagnosed with ANCA-Associated Vasculitis \(AAV\). But everything quietly shifts. The disease rarely shows on the outside, yet it reaches into every corner of a person’s life. Yes, the body is affected—joint pain, fatigue, or physical changes that may be visible. But what truly defines the experience of living with AAV often lies beneath the surface. A promising career might be paused indefinitely. The plans, routines, and relationships that once felt solid begin to feel fragile. Even simple joys become difficult to hold onto when your body is in constant survival mode. The emotional weight is real—and often underestimated. There’s the fear of losing independence, the pressure of financial instability, the strain it can place on the people you love most, on a relationship with a partner. AAV affect how people see themselves, how they relate to others, how they envision their future. AAV doesn’t just attack the body—it attacks one’s sense of identity, stability, and purpose. That’s the side of AAV we don’t talk about enough. And that’s the side we’re here to acknowledge today. At CSL, we believe raising awareness means seeing the full picture. Not just the medical symptoms, but the human experience behind them. Because living with AAV is more than managing inflammation—it's managing life. Join us in supporting all those whose battles may be invisible, but never insignificant. Learn more on https://bit.ly/43s07Ki #AAVAwareness #LifeWithAAV

At CSL, sustainability isn’t just a buzzword. It’s embedded in everything we do across the globe. We’re committed to reducing emissions, rethinking resources and designing facilities that support a healthier, more sustainable future. #PromisingFutures #CSL Reinvent the world with us: https://bit.ly/4kxW7z9

Vickie, who is living with end-stage kidney disease, is participating in a clinical trial and encourages researchers to keep looking for answers. Today is #ClinicalTrialsDay https://bit.ly/43jMjSc

CSL is delighted to announce the appointment of Mary Oates as the new Chief Operating Officer. In this pivotal role, Mary will lead CSL’s enterprise Operations organization, encompassing manufacturing, quality, supply chain, technical operations, and network strategy. Mary brings a wealth of leadership expertise spanning more than 25 years in the biopharmaceutical industry. We extend our warmest welcome to Mary and look forward to the impact she will make. Click here to learn more about our leadership: https://bit.ly/3SeDdkF #CSL #Leadership #DrivenByOurPromise

On #HAEDay , we’re proud to unite with the hereditary angioedema \(#HAE \) community in raising awareness of this rare and debilitating genetic disease. Our commitment to advancing treatments for HAE remains steadfast. Our ultimate goal is to improve the quality of life for people like Arianna, who courageously navigate the day-to-day fear of experiencing a painful and potentially life-threatening swelling attack. Together, we can drive innovation and work towards a future where those affected by HAE can live without fear of attacks. Read more of Arianna’s experience with HAE and her hopes for the future of HAE treatment: https://lnkd.in/eT9XUEjU #CSL

🌎 Today, on International Vasculitis Day \(IVD\), we are happy to celebrate a major step forward in raising global awareness for vasculitis: the introduction of the first-ever official logo for IVD. This new visual identity, developed by Vasculitis International and chosen by the global patient community, marks a significant milestone in amplifying the visibility of this rare and complex group of diseases — and we are proud to have supported this important initiative. See the logo here https://lnkd.in/eVus29X3 At CSL, we understand that living with ANCA-Associated Vasculitis \(AAV\), a type of rare and severe vasculitis, is about far more than managing a medical condition. It’s about navigating a journey marked by uncertainty and challenges — many of which remain invisible. That’s why our commitment goes beyond developing treatments. We believe true innovation is only possible when we walk alongside patients and truly listen to their voices. Through initiatives like the Vasculitis Together, and hand-in-hand with patients, advocates, and partners worldwide, we are driving forward progress — because behind every innovation, there is a human story that matters. On this important day, we invite you to hear directly from AAV patients Catherine and Shanali — voices that inspire all of us in CSL to push forward. Today, we reaffirm our promise: We see you. We hear you. We stand with you. Learn more on AAV https://lnkd.in/eM5Tn-8C #VasculitisDay #AAVAwareness #HolisticCare #LifeWithAAV #IVD2025

Today, on IgAN Awareness Day, we stand with everyone affected by IgA nephropathy — a rare, chronic kidney disease that can ultimately lead to kidney failure. Also known as Berger’s disease, IgAN impacts approximately 2.5 in 100,000 people per year worldwide. Its early symptoms are often subtle or absent, which means many live with the condition for years before receiving a diagnosis. While it can affect anyone, IgAN is most commonly diagnosed in young adults between their teens and late 30s — often just as they're planning their futures. At CSL, we are deeply committed to making a meaningful difference for people living with IgAN. We are proud our innovative treatment for IgAN has been converted from conditional to standard marketing approval in the European Union — a major step forward that will offer new hope to more patients and their families across Europe. But innovation doesn’t stop at treatment. Through initiatives like My Kidney House https://bit.ly/3GSDkjv, we provide patients and caregivers with reliable, easy-to-understand resources to help them better navigate their healthcare journey. Awareness matters. Early diagnosis matters. Innovation matters. And at CSL, we’ll continue to advance science and amplify support — because every person living with IgAN deserves to be seen, heard, and helped. Learn more about how IgAN impacts the kidneys by watching our short explainer video here https://bit.ly/44C34ug? #IgANAwarenessDay #KidneyHealth #KidneyDisease #MyKidneyHouse #CSL

Tomorrow’s medical breakthroughs start today. At CSL, research is about making discoveries that lead to impact. Join a team dedicated to shaping the future of medicine. #PromisingFutures #CSL Explore opportunities: https://bit.ly/44w86bC